United Therapeutics (UTHR) Operating Expenses (2009 - 2026)
United Therapeutics (UTHR) posted Operating Expenses of $455.7 million for Q1 2026, up 5.12% sequentially from $433.5 million in Q4 2025, and up 10.71% YoY from $411.6 million in Q1 2025.
United Therapeutics (UTHR) Operating Expenses (2009 - 2026) Analysis & Trends
United Therapeutics has reported Operating Expenses for 18 years, with the latest figure at $455.7 million in Q1 2026.
- Quarterly Operating Expenses rose 10.71% year-over-year to $455.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (up 9.03% YoY) and the FY2025 annual result came in at $1.7 billion, up 12.65% from the prior year.
- Operating Expenses rose to $455.7 million in Q1 2026 per UTHR's latest filing, from $433.5 million in the prior quarter.
- Over five years, Operating Expenses peaked at $455.7 million in Q1 2026 and troughed at $173.9 million in Q1 2022.
- A 5-year average of $338.0 million and a median of $354.6 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2024: Operating Expenses slumped 60.82% in 2022, then jumped 44.45% in 2024.
- Over 5 years, Operating Expenses stood at $315.9 million in 2022, then rose by 12.25% to $354.6 million in 2023, then advanced by 6.66% to $378.2 million in 2024, then increased by 14.62% to $433.5 million in 2025, then grew by 5.12% to $455.7 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $455.7 million, $433.5 million, and $411.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn | 477.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 452.50 Mn |
| Mar 31, 2026 | 455.70 Mn |
| Dec 31, 2025 | 433.50 Mn |
| Sep 30, 2025 | 411.00 Mn |
| Jun 30, 2025 | 434.10 Mn |
| Mar 31, 2025 | 411.60 Mn |
| Dec 31, 2024 | 378.20 Mn |
| Sep 30, 2024 | 405.80 Mn |
| Jun 30, 2024 | 395.00 Mn |
| Mar 31, 2024 | 321.40 Mn |
| Dec 31, 2023 | 354.60 Mn |
| Sep 30, 2023 | 282.40 Mn |
| Jun 30, 2023 | 283.10 Mn |
| Mar 31, 2023 | 222.50 Mn |
| Dec 31, 2022 | 315.90 Mn |
| Sep 30, 2022 | 201.70 Mn |
| Jun 30, 2022 | 265.10 Mn |
| Mar 31, 2022 | 173.90 Mn |
| Dec 31, 2021 | 245.40 Mn |
| Sep 30, 2021 | 216.00 Mn |